{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:58:49Z","timestamp":1783796329822,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.transproceed.2021.04.010","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:54:11Z","timestamp":1620946451000},"page":"2021-2028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation"],"prefix":"10.1016","volume":"53","author":[{"given":"Suluk","family":"Itsaradisaikul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samart","family":"Pakakasama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophida","family":"Boonsathorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonnamet","family":"Techasaensiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasivimol","family":"Rattanasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nopporn","family":"Apiwattanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.04.010_bib0001","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/320871","article-title":"Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants","volume":"33","author":"Ninin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0002","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1086\/591969","article-title":"Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation","volume":"47","author":"Garcia-Vidal","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0003","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bbmt.2014.03.004","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"Suppl. 1","key":"10.1016\/j.transproceed.2021.04.010_bib0004","doi-asserted-by":"crossref","first-page":"i23","DOI":"10.1093\/jac\/dki221","article-title":"Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies","volume":"56","author":"Glasmacher","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0005","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1128\/AAC.00141-12","article-title":"Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration","volume":"56","author":"Al-Nakeeb","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0006","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/323020","article-title":"Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS","volume":"33","author":"Caillot","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0007","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0924-8579(95)00043-7","article-title":"Itraconazole: pharmacology, clinical experience and future development","volume":"6","author":"De Beule","year":"1996","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0008","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1128\/AAC.44.7.1887-1893.2000","article-title":"Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B","volume":"44","author":"Harousseau","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/sj.bmt.1705418","article-title":"A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients","volume":"38","author":"Oren","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0010","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-138-9-200305060-00006","article-title":"Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial","volume":"138","author":"Winston","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0011","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pbc.24847","article-title":"Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients","volume":"61","author":"Science","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0012","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1200\/JCO.18.00374","article-title":"Antimicrobial prophylaxis for adult patients with cancer-related immunosuppression: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0013","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1182\/blood-2003-08-2644","article-title":"Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants","volume":"103","author":"Marr","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0014","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2141.2011.08838.x","article-title":"Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation","volume":"155","author":"Marks","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0016","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0017","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/bmt.2010.185","article-title":"Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole vs itraconazole in allogeneic blood and marrow transplantation","volume":"46","author":"Sanchez-Ortega","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0018","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1111\/tid.12913","article-title":"Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children's hospital in Argentina","volume":"20","author":"Gomez","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0019","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/mmy\/myy015","article-title":"Risks and outcomes of invasive fungal infections in pediatric allogeneic hematopoietic stem cell transplant recipients receiving fluconazole prophylaxis: a multicenter cohort study by the Turkish Pediatric Bone Marrow Transplantation Study Group","volume":"57","author":"Hazar","year":"2019","journal-title":"Med Mycol"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9343(94)90023-X","article-title":"NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis","volume":"97","author":"Denning","year":"1994","journal-title":"Am J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.transproceed.2021.04.010_bib0021","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0924-8579(08)70012-8","article-title":"Risk factors for invasive fungal infections in haematopoietic stem cell transplantation","volume":"32","author":"Camps","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0022","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0023","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11046-017-0115-y","article-title":"Risk factors and outcomes of invasive fungal infections in allogeneic hematopoietic cell transplant recipients","volume":"182","author":"Miceli","year":"2017","journal-title":"Mycopathologia"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s15010-018-01265-3","article-title":"Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study","volume":"47","author":"Jin","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0026","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0027","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/13693786.2012.687462","article-title":"Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients","volume":"51","author":"Benet","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0028","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/clinids\/21.2.361","article-title":"Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen","volume":"21","author":"Bow","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0029","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/INF.0000000000002010","article-title":"Risk factors for invasive fungal infection in children and adolescents with hematologic and malignant diseases: a 10-year analysis in a single institute in Japan","volume":"37","author":"Kobayashi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1704628","article-title":"Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis","volume":"34","author":"Altes","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2021.04.010_bib0031","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1702023","article-title":"Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders","volume":"24","author":"Foot","year":"1999","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521002578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521002578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:09Z","timestamp":1758577209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521002578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0041134521002578"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.04.010","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}